Why choose Vision Camberwell
WHAT IS MYOPIA?
As a result of the eyeball growing too long in relation to the power of the eyes lenses, light focuses at a point in front of the retina rather than directly on its surface, producing poor distance vision but clear near vision. This vision distortion is known as myopia (shortsightedness).
Myopia usually presents in childhood and often runs in families, however, children are becoming more shortsighted without a family history, with myopia development being linked to environmental factors such as near work and lack of time spent outdoors.
MYOPIA PROGRESSION AND ASSOCIATED RISKS
Youth onset myopia generally progresses more aggressively than adult onset myopia, and typically requires glasses or contact lenses to be frequently replaced as and when myopia progresses.
Unfortunately, myopia increases the chance of blinding conditions such as cataracts, glaucoma, myopia retinal degeneration and retinal detachment. The risks for developing these sight-threatening conditions escalate as the level of myopia increases.
Studies show the risk for glaucoma and cataract due to myopia compares with the risk of stroke for a smoker smoking 20 cigarettes per day, with the risk factor for eye disease development from myopia being comparable to the risk of cardiovascular disease from elevated blood pressure. The risk for retinal detachment and myopic maculopathy with myopia is far in excess of any identified population risk factor for cardiovascular disease.
Halting myopia progression can broadly prevent a significant level of sight threatening conditions and blindness.
While prescribing standard spectacle lenses or contact lenses will help correct vision, these options do not halt myopia progression. Because myopia cannot be reversed, it is critical to halt progression as early as possible.
Evidence shows that certain treatments can slow (and even halt) myopia progression, with Orthokeratology (OrthoK), a treatment prescribed to correct vision overnight, being one of the most effective treatments that slows or halts myopia progression.
With research showing a 32%-100% slowing in the rate of myopia progression through OrthoK treatment, most reports suggest 50% progression reduction on average. Shonit, one of few optometrists in Australia to receive a Fellowship with the International Academy of Orthokeratology and Myopia Control, and having been involved in the groundbreaking Research and Development team within Innovative Contacts who developed the revolutionary Forge OrthoK lenses, has completely halted myopia progression in many patients. Shonit successfully fits clients from six years of age.